Welcome
The Gastroenterology Foundation of South Africa was established in 2006 with the aim of contributing towards the continuing medical education of medical and surgical Gastroenterologists and Hepatologists.
Read more >>
Upcoming Event
|
Liver Interest Group Meeting Date: Saturday 30 November 2019 Venue: Vineyard Hotel, Cape Town |
News
Blog
|
A Dynamic Duo of Eponymous Lectures – A Visit by Dr Jay Hoofnagle
|
|
 Prof Wendy Spearman |
Prof Mashiko Setshedi
|
|
Dr Jay Hoofnagle, Director of the Liver Disease Research Branch in the Division of Digestive Diseases and Nutrition of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) in Bethesda, Maryland, USA was the 2019 Solly Marks Visiting Professor. He visited the Groote Schuur Hospital/University of Cape Town Divisions of Gastroenterology and Hepatology from 12-19 August 2019 His programme included joining the Liver Clinic, GIT and Liver academic rounds as well as the histology meetings and interacting with consultants, GIT Fellows and medical registrars. |
|
|
The Solly Marks Lecture was on “New challenges in Drug-induced Liver Injury”. Drug-induced liver injury (DILI) is an important disease entity as it is the most common cause of acute liver failure and a common reason for FDA non-approval or withdrawal of an agent from clinical use. 3-5% of hospital admissions for jaundice are due to DILI and it is a major reason for a liver consultation. This is very relevant to South Africa where many admissionsin the setting of HIV are due to Efavirenz or Tuberculous drug-induced liver injuries which are associated with significant morbidity and mortality. Globally, antimicrobials are the most common causes of DILI with amoxicillin/clavulanic acid being the main culprit, but increasingly herbal and dietary supplements are causes of DILI. Read more |
|